Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alpha TeknovaTKNO +0.56%63 Days Inventory is 87.13 as of Mar. 2026, which is 7% below its 10-year median of 93.38. GuruFocus rates TKNO with a GF Score™ of 63/100 and a GF Value™ of $3.55 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Alpha Teknova ranks better than 82.74% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Alpha Teknova's Average Total Inventories for the
three
months ended in Mar. 2026 was $6.96 Mil. Alpha Teknova's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $7.29 Mil.
Hence, Alpha Teknova's Days Inventory for the
three
months ended in Mar. 2026 was 87.13.
The historical rank and industry rank for Alpha Teknova's Days Inventory or its related term are showing as below:
TKNO'
s Days Inventory Range Over the Past 10 Years
Min: 81.3 Med: 93.38 Max: 164.88
Current: 92.69
During the past 7 years, Alpha Teknova's highest Days Inventory was 164.88. The lowest was 81.30. And the median was 93.38.
TKNO's Days Inventory is ranked better than 82.74% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs TKNO: 92.69
Alpha Teknova's Days Inventory
declined
from Mar. 2025 (89.89) to Mar. 2026 (87.13).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Alpha Teknova's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.05.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alpha Teknova's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.63.
Alpha Teknova (NAS:TKNO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Alpha Teknova's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Alpha Teknova's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Alpha Teknova Days Inventory Related Terms
Alpha Teknova Days Inventory Historical Data
* Premium members only.
The historical data trend for Alpha Teknova's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TKNO vs AKBA, ORGO, SIGA: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alpha Teknova Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's Days Inventory distribution charts can be found below:
* The bar in red indicates where Alpha Teknova's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alpha Teknova (TKNO) has a Days Inventory of 87.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alpha Teknova and its competitors. This is near median its historical median of 93.38. Over the past decade, Alpha Teknova's Days Inventory has ranged from 81.30 to 164.88. According to the industry distribution chart, Alpha Teknova ranks #159 out of 921 companies in the Drug Manufacturers industry, placing it in the top 17.3%.
Is Alpha Teknova's Days Inventory too high?
Alpha Teknova's current Days Inventory of 87.13 is near median its 10-year median of 93.38. Over the past 10 years, this metric has ranged from a low of 81.30 to a high of 164.88. The Drug Manufacturers industry median Days Inventory is 164.48. Alpha Teknova's value of 87.13 is 47% below this industry median. Based on the distribution chart, Alpha Teknova ranks #159 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Alpha Teknova has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alpha Teknova's Days Inventory compare to AKBA and ORGO?
According to the Drug Manufacturers industry distribution chart, Alpha Teknova ranks #159 out of 921 companies for Days Inventory. This places Alpha Teknova in the top 17% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Alpha Teknova's value of 87.13 is 47% below this benchmark. Historically, Alpha Teknova's own Days Inventory has ranged from 81.30 to 164.88 over the past decade. While the company's 10-year median is 93.38 vs. the industry median of 164.48, Alpha Teknova has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Teknova's current Days Inventory of 87.13 is 47% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Alpha Teknova and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Teknova's current Days Inventory is 87.13, which is near median its own 10-year median of 93.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Teknova stock overvalued right now?
Based on GuruFocus' analysis, Alpha Teknova (TKNO) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.55, compared to a current price of $5.34 — trading 50.4% above its estimated fair value. The current Days Inventory is 87.13, which is near median its 10-year median of 93.38 and 47% below the Drug Manufacturers industry median of 164.48. Alpha Teknova's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Alpha Teknova (TKNO), the current Days Inventory is 87.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alpha Teknova (TKNO) Overvalued in 2026?
Based on GuruFocus' analysis, Alpha Teknova stock appears to be overvalued.
The current stock price of $5.34 is trading 50.4% above its estimated GF Value™ of $3.55.
GuruFocus considers Alpha Teknova to be Significantly Overvalued.
Key valuation signals for TKNO:
Days Inventory: 87.13 (near median its 10-year median of 93.38)
GF Value™: $3.55 vs. price of $5.34 (50.4% above fair value)
Industry Position: 47% below the Drug Manufacturers median (#159 of 921)
No single metric tells the full story. See the TKNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
63GF Score
Get the complete analysis for TKNO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TKNO has been successfully added to your 
